Neutral
Arrowhead Pharmaceuticals | SCHEDULE 13G: Others
This article provides a document related to a SCHEDULE 13G filing for Arrowhead Pharmaceuticals, indicating actions taken by "Others" in connection wi...
This article provides a document related to a SCHEDULE 13G filing for Arrowhead Pharmaceuticals, indicating actions taken by "Others" in connection wi...
Neutral
China Universal Asset Management Co. Ltd. reduced its stake in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 28.7% in the 4...
Neutral
China Universal Asset Management Co. Ltd. cut its holdings in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 28.7% in the fourth quart...
Neutral
Arrowhead Pharmaceuticals, Inc. announced it will host a webcast and conference call on May 7, 2026, at 4:30 p.m. ET to discuss its fiscal 2026 second...